This covers the whole spectrum of products and solutions.
Key Cannabis | Hemp | CBD figures and statistics
According to Arcview Market Research and BDS Analytics, spending on legal cannabis worldwide is expected to hit $57 billion by 2027.
Orthogonal Thinker currently owns equity in Meadow(read more about Meadow below). We have invested $171K cumulatively in 3 different early rounds. We have a commitment in place to put an additional $1 million into their series A round, which has a valuation of $40 million.
Orthogonal Thinker was also one of the first investors in the seed round of Confident Cannabis, which has a current valuation of $100 Million. They are a research, testing and database trading platform for the cannabis industry.
The rise of the Cannabis, Hemp and CBD markets across the US and the world is one of the greatest investing opportunities of the 21st century. Orthogonal has been a pioneer in these markets for over a decade. I’ve seen the good and the bad across all sectors of the industry. Fortunately, bad actors are being “weeded” out as regulations and compliance take center stage.
At the same time, companies with high-quality products, solid business plans and competent teams are set to prosper over the next 10 years and beyond. The numbers are enough to whet the appetite of any visionary and socially conscious investor. According to Arcview Market Research and BDS Analytics, spending on legal cannabis worldwide is expected to hit $57 billion by 2027.
As of November 2018, 10 states and the District of Columbia have passed adult-use laws. In addition, the majority of states have of some type of medicinal cannabis law.
Around the globe, Uruguay and Canada have legalized recreational marijuana on a national level. Australia, Colombia, Germany, Greece, Poland and Zimbabwe along with more than 30 countries have passed medical cannabis laws. These next 2-3 years will be pivotal. The great game changer was the signing of the Farm Bill at the end of 2018.
This bill removed hemp from the federal government’s list of controlled substances. This paves the way for hemp to become a major agricultural and industrial crop again.
What’s more... hemp products, including CBD products, can now be legally sold across state lines and national borders. To this point, research firm Brightfield Group says the market for CBD may grow by 40x to hit $22 billion by 2022.⁵ This is huge.
Our strategy to capitalize on this megatrend is multi-fold. First, Orthogonal Thinker currently owns equity in Meadow. We have invested $171K cumulatively in 3 different early rounds.
We have a commitment in place to put an additional $1 million into their series A round, which has a valuation of $40 million. Meadow’s Point of Sale software solution is quickly becoming a dominant force in the industry.
By Q2 of 2019 they expect to control 20% of the California dispensary market. In 2019, they will expand into other states and internationally as well.
Second, we’re currently planning a strategic acquisition of intellectual property in the Hemp/CBD space with potential 100% ownership. This will be a made on Maui line of premium quality CBD products with full vertical integration.